Treatments for rare diseases have generally been able to avoid the most aggressive payer management strategies, like step therapy. Chalk up this immunity to limited treatment options for these diseases, relatively few patients needing treatment for them, and vocal advocacy communities. So when pharmacy benefit managers introduced exclusion lists earlier this decade, it wasn’t much of a surprise that rare diseases were virtually absent from them.

That immunity is being challenged. In 2017, CVS Caremark began excluding drugs in the chronic myelogenous leukemia category. Patients who want to use excluded drugs may be required to pay full cost unless an exception is allowed, which often requires the patient to try a preferred drug — and fail on it — first.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Hi again. Technology!!
    I wanted to comment that I am a Chinese Traditional Medicine practitioner. I thought you would like to understand about what solutions acupuncture and our way of diagnosis and treatment can do for Western Medicine especially as new “diseases” are cropping up. It is amazing what we can help with to help symptoms resolve themselves and they patients are living a quality of life again. My wish see a marriage between Western Medicine and Eastern Medicine, and encouraged for patients to seek licensed practitioners. We are seeing some of this happen by default because of the opioid crises. I was just saying to our board of directors that most Americans really don’t understand how a “Licensed acupuncturist” can help them. Dry needling is a farce by-the-way. It is someone’s good idea of taking a 3000-year-old medicine and trying to re-brand it as something western. What is called dry-needling is a specialty in China that has been around for about 1000 years. Trust me, I have interned in China and I’ve seen it there. There is a lot of problems around Dry-needling.
    Firstly, if Physical Therapist do it, they take a weekend class – 20 hours to 40 hours, and start practicing on their patients that come in. Licensed Acupuncturist who went to a 4-year school has 2700 hours of class time 300-600 hours of clinic time. Big difference! Also, PTs are causing many pneumothorax problems that lead to hospitalization and nerve damage to various parts of bodies.
    I just wanted to let you know others that want to be “in-the=know” around western medicine and drugs, and politics. You guys are doing an amazing job
    Contact me if you would like. And, thank you all. Love your articles.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy